🔓
Sign in as a Member to unlock the full view of AVNS. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
AVNS

Avanos Medical, Inc.

Sector: healthcareMedical - DevicesNYSEMarket Cap: $717.6M

Avanos Medical develops medical devices for pain management and digestive health, with zero federal contracts, zero lobbying spend, and a single recent corporate insider buy of $439.8K against no political engagement.

Next filing → your inbox
Govt Dependence
0/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat AVNS does

Avanos Medical operates in the healthcare sector, focusing on medical device manufacturing for pain management and digestive health. Its revenue lines include interventional pain and digestive health products. The company has no reported federal contracts or lobbying expenditures.

12 months past · 3 months futureAVNS activity timeline

$26$18$11 NovDecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27 ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Oct 12 $25.05 hi $11.13 lo $24.99 CONGRESS 2 INSIDERS 0 13F FUNDS 30 BILLS 26 D.E. Shaw & Co. · holds $12M · 2025-12-31AQR Capital Management · OPENED $10M · 2026-03-31D.E. Shaw & Co. · - $9M · 2026-03-31D.E. Shaw & Co. · - $7M · 2026-06-30Citadel Advisors · + $7M · 2026-03-31Renaissance Technologies · OPENED $6M · 2026-06-30Citadel Advisors · + $5M · 2025-12-31AQR Capital Management · - $3M · 2026-06-30Two Sigma Investments · OPENED $2M · 2025-12-31Two Sigma Investments · - $1M · 2026-03-31Two Sigma Investments · - $1M · 2026-06-30 S.222 · enacted · 2026-01-14HR.658 · passed_one · 2026-02-03HR.498 · passed_one · 2025-12-18HR.499 · committee · 2025-12-19 MARKUP · House Education and Workforce · 2026-10-23
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
167 trading days · 0 congressional trades shown · 0 insider buys · 11 13F filings · 4 past bill actions · 1 upcoming markups

Lifetime Government AwardsAVNS federal contracts

AVNS doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding AVNS

$17.3M
Total AVNS held by tracked 13F funds
4
Funds with AVNS positions
+1
Funds opened this quarter
D.E. Shaw & Co. $7M -58% 2026-06-30
Renaissance Technologies $6M opened 2026-06-30
AQR Capital Management $3M -84% 2026-06-30
Two Sigma Investments $1M -46% 2026-06-30

Congressional TradesWho in Congress is trading AVNS

2020-03-17 Van Taylor R-TX · house sale $1,001 - $15,000
2020-03-17 Van Taylor R-TX · house Sale $1,001 - $15,000
2+ trades on file · most recent 2020-04-13

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

3
stock awards · $14.9M market value
2026-07-27 Pacitti David Chief Executive Officer AWARD 444,730 sh $11.1M
2026-07-27 Galovan Scott Michael SVP, Chief Financial Officer AWARD 96,121 sh $2.4M
2026-07-27 Delgado Sigfrido SVP, Operations AWARD 54,886 sh $1.4M
For AVNS, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting AVNSLive legislation impacting this stock

Political ProfileWhere AVNS sits in Washington

[object Object]

STRUCTURAL: Zero lobbying spend (get_political_influence.lobbying.total_income: 0), zero federal contracts (get_government_precedent.federal_contracts_summary: null), and zero political contributions. EVIDENTIARY: Single corporate insider buy of $439.8K (Recent corp insider Form 4 buys[0].total_value: 439799.99999999994) but no cluster or CEO/CFO buys (get_corporate_insider_signal.ceo_cfo_buys: 0). Net: Minimal political exposure with slight insider buying.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Healthcare legislation impacting revenue
    Congress
    "Recent bill_impacts shows 8 healthcare bills with impact_ratios 0.0068-0.0071, each estimated revenue impact $4.87M-$5.13M."

Regulatory opportunities

  • No specific regulatory opportunities flagged.
Member intelligence layer

Live signals + predictions for AVNS — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout AVNS & political exposure

Does Avanos Medical, Inc. (AVNS) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Avanos Medical, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded AVNS stock?
2 congressional trades by 1 unique members of Congress, most recently on 2020-03-17. See the Congressional Trading panel for politician-by-politician breakdown.
What is AVNS political risk profile?
Government dependence: 0/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track AVNS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. AVNS data is updated daily from these official federal sources.